Skip to contentCRANDELL KEITH — Quanterix Corp insider: 260 transactions · InsiderLensCRANDELL KEITH
- 10% owner at Neumora Therapeutics, Inc. · on record since Sep 29, 2023
- 10% owner at BOLD ENERGY INC. · on record since Mar 27, 2024
- 10% owner at Trubion Pharmaceuticals, Inc · on record since Oct 25, 2006
- Director at CELEBRATE EXPRESS, INC. · on record since Oct 23, 2006
- 10% owner at Rapport Therapeutics, Inc. · on record since Jun 10, 2024
- 10% owner at NeurogesX Inc · on record since May 9, 2007
- 10% owner at Maze Therapeutics, Inc. · on record since Jan 30, 2025
- 10% owner at Metsera, Inc. · on record since Jan 30, 2025
- 10% owner at CELEBRATE EXPRESS, INC. · on record since Oct 23, 2007
- Director at Metsera, Inc. · on record since Nov 14, 2025
- 10% owner at Kardigan, Inc. · on record since Jun 18, 2026
- 10% owner at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 1, 2004
- 10% owner at Lyell Immunopharma, Inc. · on record since Jun 23, 2021
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- Director at APROPOS TECHNOLOGY INC · on record since Jun 9, 2004
- 10% owner at APROPOS TECHNOLOGY INC · on record since Jun 9, 2004
- 10% owner at Seaport Therapeutics, Inc. · on record since Apr 30, 2026
- 10% owner at ILLUMINA INC · on record since Dec 1, 2003
- 10% owner at KYTHERA BIOPHARMACEUTICALS INC · on record since Oct 16, 2012
- 10% owner at BLUE HOLDINGS, INC. · on record since Jun 26, 2013
- 10% owner at Receptos, Inc. · on record since May 14, 2013
- 10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Jul 31, 2013
- 10% owner at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- Former 10% Holder at ILLUMINA INC · on record since Feb 5, 2004
- 10% owner at Achaogen Inc · on record since Mar 17, 2014
- Director at 908 Devices Inc. · on record since Jun 12, 2026
- 10% owner at SAGE FUND LP · on record since Jul 23, 2014
- 10% owner at PAULSON CAPITAL CORP · on record since Aug 4, 2014
- 10% owner at JUNO LIGHTING INC · on record since Dec 23, 2014
- 10% owner at XCYTE THERAPIES INC · on record since Mar 10, 2004
- 10% owner at Bellerophon Therapeutics, Inc. · on record since Feb 23, 2015
- 10% owner at Ruthigen, Inc. · on record since Jun 25, 2015
- Director at ADESTO TECHNOLOGIES Corp · on record since Oct 28, 2015
- 10% owner at ADESTO TECHNOLOGIES Corp · on record since Oct 28, 2015
- 10% owner at XTERA COMMUNICATIONS, INC. · on record since Nov 18, 2015
- 10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- 10% owner at PHASERX, INC. · on record since May 25, 2016
- 10% owner at IMPINJ INC · on record since Aug 30, 2016
- 10% owner at Sienna Biopharmaceuticals, Inc. · on record since Jul 26, 2017
- Director at Quanterix Corp · on record since Dec 13, 2017
- 10% owner at Quanterix Corp · on record since Dec 13, 2017
- 10% owner at Denali Therapeutics Inc. · on record since Dec 12, 2017
- 10% owner at Q32 Bio Inc. · on record since Mar 27, 2018
- 10% owner at Scholar Rock Holding Corp · on record since May 31, 2018
- 10% owner at Unity Biotechnology, Inc. · on record since May 7, 2018
- Former 10% owner at Ruthigen, Inc. · on record since Apr 5, 2018
- Director at Twist Bioscience Corp · on record since Oct 30, 2018
- 10% owner at Twist Bioscience Corp · on record since Oct 30, 2018
- 10% owner at Gossamer Bio, Inc. · on record since Feb 12, 2019
- 10% owner at Karuna Therapeutics, Inc. · on record since Jun 27, 2019
- 10% owner at CHARTWELL DIVIDEND & INCOME FUND INC · on record since Aug 12, 2019
- 10% owner at VIRCO MFG CORPORATION · on record since Oct 18, 2019
- 10% owner at Beam Therapeutics Inc. · on record since Feb 11, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at 908 Devices Inc. · on record since Dec 22, 2020
- 10% owner at Codiak BioSciences, Inc. · on record since Oct 20, 2020
- 10% owner at Sana Biotechnology, Inc. · on record since Feb 10, 2021
- Director at DA32 Life Science Tech Acquisition Corp. · on record since Jul 27, 2021
- 10% owner at DA32 Life Science Tech Acquisition Corp. · on record since Jul 27, 2021
- 10% owner at Erasca, Inc. · on record since Jul 20, 2021
- 10% owner at Prime Medicine, Inc. · on record since Oct 26, 2022
- Director at Kardigan, Inc. · on record since Jun 24, 2026
Insider trading activity of CRANDELL KEITH
- Transactions on record
- 260
- since Dec 1, 2003
- Open-market buys
- 10
- $34.6M
- Open-market sells
- 5
- $12.6M
- Companies traded
- 14
- last filing Jun 12, 2026
Figures computed from official regulatory filings — methodology.
Companies where CRANDELL KEITH has traded
- 908 Devices Inc.30 tx · $6M · Jun 12, 2026
- Twist Bioscience Corp50 tx · $13.6M · Feb 9, 2026
- DA32 Life Science Tech Acquisition Corp.4 tx · $22.5M · Aug 10, 2023
- Quanterix Corp85 tx · $4.3M · Apr 4, 2023
- VIRCO MFG CORPORATION10 tx · Sep 1, 2022
- Codiak BioSciences, Inc.11 tx · $3.5M · Oct 20, 2020
- ADESTO TECHNOLOGIES Corp16 tx · $2M · Jun 6, 2019
- XTERA COMMUNICATIONS, INC.8 tx · $1.5M · Sep 28, 2016
- Ruthigen, Inc.4 tx · $500.5K · Jun 17, 2015
Track record of CRANDELL KEITH
Statistical track record
Free- Open-market buys
- 12
- Last buy
- Jul 30, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of CRANDELL KEITH
Co-insiders of CRANDELL KEITH
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
13 tx · $1.8M · Oct 16, 2012
ARCH Venture Partners IX, LLCBeam Therapeutics Inc. +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 12, 2026 | Exercise | 14,083 | — | — | SEC |
| Jun 12, 2026 | AwardD | 6,209 | 0.00 USD | $0 | SEC |
| Jun 12, 2026 | AwardD | 13,656 | 0.00 USD | $0 | SEC |
| Jun 12, 2026 | ExerciseD | -14,083 | 0.00 USD | $0 | SEC |
| Feb 9, 2026 | Award | 5,095 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | ExerciseD | -11,364 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 14,083 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 6,516 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | Exercise | 11,364 | — | — | SEC |
| Feb 7, 2025 | Award | 4,472 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | AwardD | 11,364 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | Exercise | 7,777 | — | — | SEC |
| Jun 14, 2024 | AwardD | 15,996 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | ExerciseD | -7,777 | 0.00 USD | $0 | SEC |
| Feb 9, 2024 | Award | 5,815 | 0.00 USD | $0 | SEC |
| Aug 10, 2023 | Other | -1,600,000 | — | — | SEC |
| Jun 16, 2023 | ExerciseD | -4,771 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 12,076 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 7,777 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | Exercise | 4,771 | — | — | SEC |
| Apr 4, 2023 | Award | 1,170 | 11.16 USD | $13.1K | SEC |
| Feb 9, 2023 | Award | 8,212 | 0.00 USD | $0 | SEC |
| Jan 4, 2023 | Award | 1,015 | 12.86 USD | $13.1K | SEC |
| Jan 4, 2023 | Award | 8,083 | 0.00 USD | $0 | SEC |
| Jan 4, 2023 | AwardD | 12,124 | 0.00 USD | $0 | SEC |